Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

331 ARTÍCULOS , VIENDO DEL 286 AL 300

Pharmacological approaches for Alzheimer's disease: neurotransmitter as drug targets

Prakash A, Kalra J, Mani V, Ramasamy K, Majeed AB.

Expert Rev Neurother. 2015 Jan;15(1):53-71. doi: 10.1586/14737175.2015.988709. Epub 2014 Dec 12.

Safety and clinical effects of EVP-6124 in subjects with Alzheimer's disease currently or previously receiving an acetylcholinesterase inhibitor medication

Deardorff WJ, Shobassy A, Grossberg GT.

Expert Rev Neurother. 2015 Jan;15(1):7-17. doi: 10.1586/14737175.2015.995639. Epub 2014 Dec 15.

An alkaline phosphatase transport mechanism in the pathogenesis of Alzheimer's disease and neurodegeneration

Pike AF, Kramer NI, Blaauboer BJ, Seinen W, Brands R.

Chem Biol Interact. 2015 Jan 25;226:30-9. doi: 10.1016/j.cbi.2014.12.006. Epub 2014 Dec 11.

Role of the nicotinic acetylcholine receptor in Alzheimer's disease pathology and treatment

Lombardo S, Maskos U.

Neuropharmacology. 2015 Sep;96(Pt B):255-62. doi: 10.1016/j.neuropharm.2014.11.018. Epub 2014 Dec 13.

Advances in the therapy of Alzheimer's disease: targeting amyloid beta and tau and perspectives for the future

Hampel H, Schneider LS, Giacobini E, Kivipelto M, Sindi S, Dubois B, Broich K, Nisticò R, Aisen PS, Lista S.

Expert Rev Neurother. 2015 Jan;15(1):83-105. doi: 10.1586/14737175.2015.995637. Epub 2014 Dec 24.

Charting a path toward combination therapy for Alzheimer's disease

Stephenson D, Perry D, Bens C, Bain LJ, Berry D, Krams M, Sperling R, Dilts D, Luthman J, Hanna D, McKew J, Temple R, Fields FO, Salloway S, Katz R.

Expert Rev Neurother. 2015 Jan;15(1):107-13. doi: 10.1586/14737175.2015.995168. Epub 2014 Dec 26.

Efficacy and safety of galantamine treatment for patients with Alzheimer's disease: a meta-analysis of randomized controlled trials

Jiang D, Yang X, Li M, Wang Y, Wang Y.

J Neural Transm (Vienna). 2015 Aug;122(8):1157-66. doi: 10.1007/s00702-014-1358-0. Epub 2014 Dec 30.

Inadequate supply of vitamins and DHA in the elderly: implications for brain aging and Alzheimer-type dementia

Mohajeri MH, Troesch B, Weber P.

Nutrition. 2015 Feb;31(2):261-75. doi: 10.1016/j.nut.2014.06.016. Epub 2014 Jul 24.

A review on Alzheimer's disease pathophysiology and its management: an update

Kumar A, Singh A, Ekavali.

Pharmacol Rep. 2015 Apr;67(2):195-203. doi: 10.1016/j.pharep.2014.09.004. Epub 2014 Sep 22.

Pharmacological treatment of neuropsychiatric symptoms in Alzheimer's disease: a systematic review and meta-analysis

Wang J, Yu JT, Wang HF, Meng XF, Wang C, Tan CC, Tan L.

J Neurol Neurosurg Psychiatry. 2015 Jan;86(1):101-9. doi: 10.1136/jnnp-2014-308112. Epub 2014 May 29.

Neuropsychiatric symptoms of dementia: are pharmacological treatments effective and safe?

Ford AH.

J Neurol Neurosurg Psychiatry. 2015 Jan;86(1):4. doi: 10.1136/jnnp-2014-308420. Epub 2014 May 29.

Follow-up evaluation of cognitive function in the randomized Alzheimer's Disease Anti-inflammatory Prevention Trial and its Follow-up Study

ADAPT-FS Research Group.

Alzheimers Dement. 2015 Feb;11(2):216-25.e1. doi: 10.1016/j.jalz.2014.03.009. Epub 2014 Jul 9.

Lifelong bilingualism and neural reserve against Alzheimer's disease: a review of findings and potential mechanisms

Gold BT.

Behav Brain Res. 2015 Mar 15;281:9-15. doi: 10.1016/j.bbr.2014.12.006. Epub 2014 Dec 8.

Donepezil treatment in ethnically diverse patients with Alzheimer disease

Tinklenberg JR, Kraemer HC, Yaffe K, O'Hara R, Ringman JM, Ashford JW, Yesavage JA, Taylor JL; California Alzheimer's Disease Centers.

Am J Geriatr Psychiatry. 2015 Apr;23(4):384-390. doi: 10.1016/j.jagp.2014.09.007. Epub 2014 Sep 28.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias